Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 3 ( May-June, 2019 ) > List of Articles


Can Human Papillomavirus Testing Replace Papanicolaou Smear in Near Future as a Screening Modality for Cervical Cancers?

Citation Information : Can Human Papillomavirus Testing Replace Papanicolaou Smear in Near Future as a Screening Modality for Cervical Cancers?. J South Asian Feder Obs Gynae 2019; 11 (3):141-143.

DOI: 10.5005/jp-journals-10006-1694

License: CC BY-NC 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2019; The Author(s).


  1. Ferlay J, Soerjomataram I, Ervik M, et al.
  3. Sankaranarayanan R, Swaminathan R, Lucas E. Cancer Survival in Africa, Asia, Caribbean and Central America: Survcan. Lyon: IARC Scientific Publication International Agency for Research on Cancer; 2010.
  4. Bobdey S, Sathwara J, Jain A, et al. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol 2016;37(4):278–285. DOI: 10.4103/0971-5851.195751.
  5. Karimi-Zarchi M, Peighmbari F, Karimi N, et al. A comparison of 3 ways of conventional Pap smear, liquid-based cytology and colposcopy vs cervical biopsy for early diagnosis of premalignant lesions or cervical cancer in women with abnormal conventional Pap test. Int J Biomed Sci 2013;9(4):205–210.
  6. Nayar R, Solomon D. Second edition of ‘The Bethesda System for reporting cervical cytology’ - Atlas, website, and Bethesda interobserver reproducibility project. Cyto Journal 2004;1(1):4. DOI: 10.1186/1742-6413-1-4.
  7. Deodhar K, Sankaranarayanan R, Jayant K, et al. Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India. Int J Cancer 2012;131(6):E954–E962. DOI: 10.1002/ijc.27633.
  8. Sankaranarayanan R. Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India 2005;18(6):281–284.
  9. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111(6):581–587. DOI: 10.1046/j.1525-1381.1999.99723.x.
  10. Arbyn M, Buntinx F, Van Ranst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96(4):280–293. DOI: 10.1093/jnci/djh037.
  11. Arbyn M, Sasieni P, Meijer CJ, et al. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006;24 (Suppl 3):S3/78–S3/89. DOI: 10.1016/j.vaccine.2006.05.117.
  12. The current NHS cervical cancer screening programme (Analysis by Bazian, Edited by NHS Website).
  13. Ogilive GS, van Niekerk D, Krajden M, et al. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months – the HPV FOCAL randomized clinical trial. JAMA 2018;320(1):43–52. DOI: 10.1001/jama.2018.7464.
  14. HPV Test May Replace Pap for Some Women By Serena Gordon, HealthDay Reporter, Tuesday, Aug. 21, 2018 (HealthDay News).
  15. Delay in replacing the Pap smear with HPV screening is costing lives by Alejandra Castanon, The Conversation.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.